Compare iShares International Treasury Bond ETF (IGOV) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares International Treasury Bond ETF vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? iShares International Treasury Bond ETF trades at $39.71 (market cap $1.30B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.72 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 45.2× iShares International Treasury Bond ETF's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.33% dividend while iShares International Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares International Treasury Bond ETF for 92 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| IGOV | TAK | |
|---|---|---|
Market Cap | $1.30B | $58.74B |
Volume | 693,740 | 3,110,994 |
Sector | Fixed Income | Health |
52-Week High | $42.99 | $19.05 |
52-Week Low | $39.65 | $13.23 |
Typical Hold Time | 92 Days | 1 Days |
Enterprise Value | — | $86.65B |
Dividend Yield | — | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IGOV trades at $39.74 with minimal daily movement (+0.1%). Technical indicators show a bearish bias with moving averages signaling selling pressure, though oscillators remain neutral. The stock faces resistance at $40 across multiple levels, indicating consolidation. Financial ratios are unavailable in current data, limiting fundamental assessment of valuation and profitability metrics.
The bearish technical setup suggests near-term caution, though neutral RSI readings indicate potential stabilization. Rising bond yields create macroeconomic headwinds for equities, but specific company fundamentals require updated SEC filings for proper evaluation. Investment appeal hinges on upcoming earnings clarity amid broader market volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
